Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost/timolol maleate combination

European Journal of Ophthalmology

Volumn 18, Issue 1, 2008, Pages 60-65

  Takmaz, Tamer ^a,b   Asik S ^a   Kurkcuoglu P ^a   Gurdal C ^a   Can, I ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Fixed combination; Glaucoma; Intraocular pressure; Latanoprost timolol

Indexed keywords

LATANOPROST; LATANOPROST PLUS TIMOLOL;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; EVENING DOSAGE; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MONOTHERAPY; MORNING DOSAGE; OPEN ANGLE GLAUCOMA; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

EID: 41149157627     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800110     Document Type: Article

References (23)

1. Zimmerman TJ, Kaufman HE. Timolol: a β-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol 1977; 95: 601-4.
2. Soil DB. Evaluation of timolol in chronic open-angle glaucoma. Once a day vs twice a day. Arch Ophthalmol 1980; 98: 2178-81.
3. Topper JE, Brubaker RF. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 1985; 26: 1315-9.
4. Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000; 41: 2566-73.
5. Watson P, Stjernschantz J, and the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126-37.
6. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993; 100: 1297-304.
7. 2α analogue reduces the intraocular pressure (IOP) in human volunteers during day and night. Invest Ophthalmol Vis Sci 1994; 35 (Suppl): S2178.
8. Racz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ. Around-the-clock (circadian) intraocular pressure reduction with once-daily application of 0.005% latanoprost by itself or in combination with timolol. Arch Ophthalmol 1996; 114: 268-73.
9. Higginbotham EJ, Feldman R, Stiles M, Dubiner H, Fixed Combination Investigative Group. Latanoprost and timolol combination therapy versus monotherapy. Arch Ophthalmol 2002; 120: 915-22.
10. Aim A, Stjernshantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily evening or morning a comparison with timolol. Ophthalmology 1995; 102: 1743-52.
11. Konstas AGP, Nakos E, Tersis I, Lallos NA, Leech JN, Stewart WC. A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol. Am J Ophthalmol 2002; 133: 753-7.
12. Watson PG, and the Latanoprost Study Group. Latanoprost two years' experience of its use in the United Kingdom. Ophthalmology 1998; 105: 82-7.
13. Pfeiffer N, the European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol 2002; 240:893-9.
14. McCannel CA, Heinrich SR, Brubaker RF. Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans. Graefes Arch Clin Exp Ophthalmol 1992; 230:518-20.
15. Reiss GR, Lee DA, Topper JE, Brubaker RF. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984; 25: 776-8.
16. Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Eye 2004; 18: 990-5.
17. Larsson L-I. The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. Acta Ophthalmol Scand 2001; 79: 125-8.
18. Larsson L-I. Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. J Glaucoma 2001; 10:109-14.
19. Stewart WC, Stewart JA, Day DG, Sharpe ED. Efficacy and safety of latanoprost/timolol maleate fixed combination versus timolol maleate and brimonidine given twice daily. Acta Ophthalmol Scand 2003; 81:242-6.
20. Konstas AGP, Boboridis K, Tzetzi D, Kallinderis K, Jenkins JN, Stewart WC. Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy. Arch Ophthalmol 2005; 123: 898-902.
21. Konstas AGP, Maltezos AC, Gandi S, Hudgins AC, Stewart WC. Comparison of the 24-hour intraocular pressure reduction with two dosing regimes of latanoprost and timolol in patients with open-angle glaucoma. Am J Ophthalmol 1999; 128: 15-20.
22. Katavisto M. The diurnal variations of ocular tension in glaucoma. Acta Ophthalmol Scand 1964; 78 (Suppl): S1-130.
23. Kitazawa Y, Horie T. Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am J Ophthalmol 1975; 79: 557-66.